• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchEditas Medicine
    Picture of Editas Medicine logo

    EDIT — Editas Medicine News Story

    $2.490.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapMomentum Trap
    • Market Cap
      $382.41m
    • Enterprise Value
      $226.51m
    • Revenue
      $40.52m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • EDIT Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    EDIT Dividends
    All News

    NASDAQ RESUMED AT 09:35 AM

    Picture of Editas Medicine logoEditas Medicine
    26/05/2026 14:35
    NASDAQ RESUMED  AT 09:35 AM

    Recent news on Editas Medicine

    See all news
    • Editas Medicine, Inc. reports results for the quarter ended June 30 - Earnings Summary

      10/08/2026 12:59
    • Editas Medicine, Inc. expected to post a loss of 27 cents a share - Earnings Preview

      07/08/2026 15:33
    • Editas Medicine Q2 net loss narrows and beats estimates

      05/08/2026 21:11
    • Brief: Editas Medicine Q2 Net Income USD -18.23 Million Vs. IBES Estimate USD -27 Million

      05/08/2026 21:02
    • Editas Medicine down after $125 mln stock-and-warrants offering

      26/05/2026 15:05

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.